Cellcept 500 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FCX9P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,032
Award facts
- Contract value 100% obligated
- $25,031.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 6, 2026, the Defense Logistics Agency awarded a $25,031.72 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for 100 tablets of CellCept 500 mg, an immunosuppressant medication commonly used in transplant and autoimmune disease management. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 7, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive contract portfolio with DLA encompasses a broad spectrum of pharmaceutical products spanning multiple therapeutic domains, from specialty medications to vaccines and medical devices. This particular delivery order exemplifies the company's role in supplying essential medications to support military treatment facilities and federal medical institutions through competitively awarded contracts utilizing firm fixed-price mechanisms.
Quick answers
Who was awarded contract SPE2DR26FCX9P?
SPE2DR26FCX9P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FCX9P worth?
The government has obligated $25,032 on SPE2DR26FCX9P.
Is contract SPE2DR26FCX9P an order under another contract?
Yes. SPE2DR26FCX9P is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCX9P competed?
The extent of competition for SPE2DR26FCX9P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award